Urokinase-type plasminogen activator soluble receptor (suPAR) assay in clinical routine: evaluation one year after its introduction in the high automation corelab of the A. Gemelli hospital.

Sarlo, Francesca; Urbani, Andrea; Baroni, Silvia

Sarlo, Francesca; Urbani, Andrea; Baroni, Silvia.

Sarlo F; UOC di Chimica Biochimica e Biologia Molecolare Clinica, Fondazione Policlinico Universitario A. Gemelli I.R.C.C.S., Rome, Italy.
Urbani A; UOC di Chimica Biochimica e Biologia Molecolare Clinica, Fondazione Policlinico Universitario A. Gemelli I.R.C.C.S., Rome, Italy.
Baroni S; Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.

Clin Chem Lab Med ; 2022 Oct 27.

Article in English | MEDLINE | ID: covidwho-2089483

Keywords

SARS-CoV-2; automation systems; soluble urokinase plasminogen activator receptor; suPAR

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Language: English Journal subject: Chemistry, Clinical / Laboratory Techniques and procedures Year: 2022 Document Type: Article Affiliation country: Cclm-2022-0686

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google